|
US5759833A
(en)
|
1994-05-27 |
1998-06-02 |
Cubist Pharmaceuticals, Inc. |
Human isoleucyl-tRNA synthetase proteins, nucleic acids and tester strains comprising same
|
|
JP2002508959A
(ja)
|
1998-01-14 |
2002-03-26 |
ヒューマン ジーン セラピー リサーチ インスティテュート |
ヒトのサプレッサーtRNAオリゴヌクレオチド、及びそれを用いる方法
|
|
US6844148B1
(en)
*
|
1998-09-24 |
2005-01-18 |
Pharmacia & Upjohn Company |
Alzheimer's disease secretase, APP substrates therefor, and uses therefor
|
|
US7465583B2
(en)
|
2000-06-01 |
2008-12-16 |
The University Of North Carolina At Chapel Hill |
Duplexed parvovirus vectors
|
|
JP5642916B2
(ja)
|
2003-04-17 |
2014-12-17 |
ザ スクリプス リサーチ インスティテュート |
真核遺伝コードの拡張
|
|
JP5275566B2
(ja)
|
2003-06-18 |
2013-08-28 |
ザ スクリプス リサーチ インスティチュート |
反応性非天然アミノ酸遺伝コード付加
|
|
US8314226B2
(en)
|
2004-03-29 |
2012-11-20 |
The General Hospital Corporation |
Oligonucleotide complex compositions and methods of use as gene alteration tools
|
|
CA2566519C
(en)
|
2004-05-14 |
2020-04-21 |
Rosetta Genomics Ltd. |
Micrornas and uses thereof
|
|
JP6047270B2
(ja)
|
2006-08-11 |
2016-12-21 |
バイオマリン テクノロジーズ ベー.フェー. |
Dnaリピートの不安定性に関連した遺伝的障害を治療するための方法及び手段
|
|
RU2510417C2
(ru)
|
2007-05-31 |
2014-03-27 |
Новозаймз, Инк. |
Способы повышения усиливающей целлюлолитической активности полипептида
|
|
US9238814B2
(en)
|
2011-05-20 |
2016-01-19 |
Fukuoka University |
Ribozyme for identifying modification on RNA sequence and RNA cleavage method using same
|
|
UA118649C2
(uk)
|
2011-11-18 |
2019-02-25 |
Елнілем Фармасьютікалз, Інк. |
ДВОЛАНЦЮГОВИЙ ЗАСІБ ДЛЯ PHKі ТА ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ДЛЯ ІНГІБУВАННЯ ЕКСПРЕСІЇ ТРАНСТИРЕТИНУ (TTR)
|
|
PT2841578T
(pt)
|
2012-04-23 |
2017-08-10 |
Biomarin Tech Bv |
Resumo
|
|
KR20150037968A
(ko)
|
2012-07-12 |
2015-04-08 |
프로큐알 테라퓨틱스 엔.브이. |
살아있는 세포 내에 존재하는 목적 rna 분자의 서열을 변화시키기 위한 올리고뉴클레오타이드
|
|
US9650627B1
(en)
|
2012-07-19 |
2017-05-16 |
University Of Puerto Rico |
Site-directed RNA editing
|
|
CN105209621B
(zh)
|
2012-12-12 |
2021-05-25 |
布罗德研究所有限公司 |
对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化
|
|
KR20250012194A
(ko)
|
2013-06-17 |
2025-01-23 |
더 브로드 인스티튜트, 인코퍼레이티드 |
바이러스 구성성분을 사용하여 장애 및 질환을 표적화하기 위한 crispr-cas 시스템 및 조성물의 전달, 용도 및 치료 적용
|
|
AU2014306271A1
(en)
|
2013-08-08 |
2016-03-24 |
The Scripps Research Institute |
A method for the site-specific enzymatic labelling of nucleic acids in vitro by incorporation of unnatural nucleotides
|
|
WO2015035091A1
(en)
|
2013-09-04 |
2015-03-12 |
Cold Spring Harbor Laboratory |
Reducing nonsense-mediated mrna decay
|
|
US20150166984A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting alpha-antitrypsin point mutations
|
|
WO2015120197A1
(en)
|
2014-02-05 |
2015-08-13 |
Regents Of The University Of California |
Rna editing biomarkers for diagnosis, pharmacological screening and prognostication in cancer
|
|
EP3129493B1
(en)
|
2014-04-09 |
2021-07-07 |
The Scripps Research Institute |
Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters
|
|
WO2015168800A1
(en)
*
|
2014-05-09 |
2015-11-12 |
UNIVERSITé LAVAL |
Prevention and treatment of alzheimer's disease by genome editing using the crispr/cas system
|
|
CA2957661A1
(en)
|
2014-08-09 |
2016-02-18 |
Kevin FLANIGAN |
Methods and materials for activating an internal ribosome entry site in exon 5 of the dmd gene
|
|
CN107532162A
(zh)
*
|
2014-12-12 |
2018-01-02 |
托德·M·伍尔夫 |
用于利用寡核苷酸编辑细胞中核酸的组合物和方法
|
|
AU2015367378A1
(en)
*
|
2014-12-17 |
2017-06-15 |
Proqr Therapeutics Ii B.V. |
Targeted RNA editing
|
|
WO2016106236A1
(en)
|
2014-12-23 |
2016-06-30 |
The Broad Institute Inc. |
Rna-targeting system
|
|
GB201503408D0
(en)
|
2015-02-27 |
2015-04-15 |
Proqr Therapeutics N V |
Oligonucleotides
|
|
GB201504124D0
(en)
|
2015-03-11 |
2015-04-22 |
Proqr Therapeutics B V |
Oligonucleotides
|
|
JP6851319B2
(ja)
|
2015-04-27 |
2021-03-31 |
ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア |
ヒト疾患のCRISPR/Cas9媒介性の修正のためのデュアルAAVベクター系
|
|
WO2017010556A1
(ja)
|
2015-07-14 |
2017-01-19 |
学校法人福岡大学 |
部位特異的rna変異導入方法およびそれに使用する標的編集ガイドrnaならびに標的rna-標的編集ガイドrna複合体
|
|
EP3957731A1
(en)
|
2015-07-15 |
2022-02-23 |
Rutgers, The State University of New Jersey |
Nuclease-independent targeted gene editing platform and uses thereof
|
|
CN117965536A
(zh)
|
2015-07-22 |
2024-05-03 |
波涛生命科学有限公司 |
寡核苷酸组合物及其方法
|
|
US11396672B2
(en)
|
2015-08-31 |
2022-07-26 |
The University Of Chicago |
Composition and methods for detecting adenosine modifications
|
|
DE102015012522B3
(de)
|
2015-09-26 |
2016-06-02 |
Eberhard Karls Universität Tübingen |
Verfahren und Substanzen zur gerichteten RNA-Editierung
|
|
AU2016335032B2
(en)
|
2015-10-05 |
2022-04-14 |
Proqr Therapeutics Ii B.V. |
Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion
|
|
MA46427A
(fr)
|
2015-10-09 |
2018-08-15 |
Wave Life Sciences Ltd |
Compositions d'oligonucléotides et procédés associés
|
|
EP3362562B1
(en)
|
2015-10-16 |
2026-07-22 |
Academisch Ziekenhuis Leiden, also acting under the name Leiden University Medical Centre (LUMC) |
Antisense oligonucleotides for use in treating alzheimer's disease
|
|
US10370667B2
(en)
|
2015-11-18 |
2019-08-06 |
Rosalind Franklin University Of Medicine And Science |
Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease
|
|
WO2017106767A1
(en)
|
2015-12-18 |
2017-06-22 |
The Scripps Research Institute |
Production of unnatural nucleotides using a crispr/cas9 system
|
|
CN108884460B
(zh)
*
|
2016-03-19 |
2023-04-28 |
埃克苏马生物技术公司 |
淋巴细胞转导及其扩增调节的方法与组合物
|
|
PL3458074T3
(pl)
|
2016-05-16 |
2024-11-12 |
Board Of Regents Of The University Of Texas System |
KOMPOZYCJA DO DOSTARCZANIA tRNA W POSTACI NANOCZĄSTEK I SPOSOBY ICH STOSOWANIA
|
|
AU2017283713B2
(en)
|
2016-06-17 |
2021-04-08 |
Massachusetts Institute Of Technology |
Type VI CRISPR orthologs and systems
|
|
EP3475424A1
(en)
|
2016-06-22 |
2019-05-01 |
ProQR Therapeutics II B.V. |
Single-stranded rna-editing oligonucleotides
|
|
EP3487998B1
(en)
|
2016-07-19 |
2023-07-12 |
Brandeis University |
Compositions and methods for identifying rna binding polypeptide targets
|
|
WO2018027078A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harard College |
Adenosine nucleobase editors and uses thereof
|
|
WO2018041973A1
(en)
|
2016-09-01 |
2018-03-08 |
Proqr Therapeutics Ii B.V. |
Chemically modified single-stranded rna-editing oligonucleotides
|
|
US10831743B2
(en)
|
2016-09-02 |
2020-11-10 |
PFFA Acquisition LLC |
Database and system architecture for analyzing multiparty interactions
|
|
GB201616202D0
(en)
|
2016-09-23 |
2016-11-09 |
Proqr Therapeutics Ii Bv |
Antisense oligonucleotides for the treatment of eye deisease
|
|
EP3565608A4
(en)
|
2017-01-05 |
2020-12-16 |
Rutgers, The State University of New Jersey |
TARGETED GENE EDITING PLATFORM INDEPENDENT OF BICATENARY DNA BREAKAGE AND ITS USES
|
|
US11274300B2
(en)
|
2017-01-19 |
2022-03-15 |
Proqr Therapeutics Ii B.V. |
Oligonucleotide complexes for use in RNA editing
|
|
CN110612353A
(zh)
|
2017-03-03 |
2019-12-24 |
加利福尼亚大学董事会 |
经由抑制性tRNAs和脱氨酶对突变进行RNA靶向
|
|
GB201706009D0
(en)
|
2017-04-13 |
2017-05-31 |
Proqr Therapeutics Ii Bv |
Antisense oligonucleotides for the treatment of stargardt disease
|
|
WO2018208998A1
(en)
|
2017-05-10 |
2018-11-15 |
The Regents Of The University Of California |
Directed editing of cellular rna via nuclear delivery of crispr/cas9
|
|
KR102678809B1
(ko)
|
2017-05-18 |
2024-06-26 |
더 브로드 인스티튜트, 인코퍼레이티드 |
표적화된 핵산 편집을 위한 시스템, 방법 및 조성물
|
|
WO2018237372A1
(en)
|
2017-06-23 |
2018-12-27 |
Cornell University |
RNA MOLECULES, METHODS FOR PRODUCING CIRCULAR RNA, AND METHODS OF TREATMENT
|
|
CN111328290A
(zh)
|
2017-06-26 |
2020-06-23 |
博德研究所 |
用于靶向核酸编辑的基于crispr/cas-腺嘌呤脱氨酶的组合物、系统和方法
|
|
WO2019014262A1
(en)
|
2017-07-11 |
2019-01-17 |
The Scripps Research Institute |
INCORPORATION OF NON-NATURAL NUCLEOTIDES AND METHODS OF IN VIVO USE THEREOF
|
|
TWI821192B
(zh)
|
2017-07-11 |
2023-11-11 |
美商新索思股份有限公司 |
非天然核苷酸之導入及其方法
|
|
EP3658573A1
(en)
|
2017-07-28 |
2020-06-03 |
President and Fellows of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
|
|
US10476825B2
(en)
|
2017-08-22 |
2019-11-12 |
Salk Institue for Biological Studies |
RNA targeting methods and compositions
|
|
GB201714027D0
(en)
|
2017-09-01 |
2017-10-18 |
Proqr Therapeutics Ii Bv |
Antisense oligonucleotides for the treatment of huntington's disease
|
|
KR20200074104A
(ko)
|
2017-10-04 |
2020-06-24 |
더 브로드 인스티튜트, 인코퍼레이티드 |
표적화된 핵산 편집을 위한 시스템, 방법, 및 조성물
|
|
IL316453A
(en)
|
2017-10-06 |
2024-12-01 |
Univ Oregon Health & Science |
RNA editing agents and methods
|
|
WO2019084062A1
(en)
|
2017-10-23 |
2019-05-02 |
The Broad Institute, Inc. |
SYSTEMS, METHODS AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITION
|
|
JP7385282B2
(ja)
|
2017-11-07 |
2023-11-22 |
ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル |
環状rna分子のための方法及び組成物
|
|
WO2019104094A2
(en)
|
2017-11-21 |
2019-05-31 |
The Regents Of The University Of California |
Fusion proteins and methods for site-directed genome editing
|
|
JP7333508B2
(ja)
|
2017-12-06 |
2023-08-25 |
学校法人福岡大学 |
オリゴヌクレオチド、その製造方法及び標的rnaの部位特異的編集方法
|
|
EP3752611A1
(en)
*
|
2018-02-14 |
2020-12-23 |
ProQR Therapeutics II B.V. |
Antisense oligonucleotides for rna editing
|
|
GB201803010D0
(en)
|
2018-02-26 |
2018-04-11 |
Royal Holloway & Bedford New College |
Neurodegenerative disorders
|
|
KR102853088B1
(ko)
|
2018-05-11 |
2025-09-02 |
빔 테라퓨틱스, 인크. |
프로그래밍가능한 염기 편집기 시스템을 이용하여 단일염기다형성을 편집하는 방법
|
|
GB201808146D0
(en)
|
2018-05-18 |
2018-07-11 |
Proqr Therapeutics Ii Bv |
Stereospecific Linkages in RNA Editing Oligonucleotides
|
|
WO2020001793A1
(en)
|
2018-06-29 |
2020-01-02 |
Eberhard-Karls-Universität Tübingen |
Artificial nucleic acids for rna editing
|
|
WO2020018918A1
(en)
|
2018-07-19 |
2020-01-23 |
The Board Of Trustees Of The University Of Illinois |
Methods for exon skipping and gene knockout using base editors
|
|
KR102950624B1
(ko)
|
2018-07-24 |
2026-04-10 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
원형 폴리리보뉴클레오티드를 포함하는 조성물 및 이의 용도
|
|
CN119193702A
(zh)
|
2018-09-06 |
2024-12-27 |
加利福尼亚大学董事会 |
经由改造的adar募集的rna和dna碱基编辑
|
|
PE20211402A1
(es)
|
2018-10-12 |
2021-08-02 |
Univ Beijing |
Metodos y composiciones para editar acidos ribonucleicos
|
|
WO2020113135A1
(en)
|
2018-11-29 |
2020-06-04 |
Flagship Pioneering Innovations V, Inc. |
Methods of modulating rna
|
|
AU2019392928A1
(en)
|
2018-12-06 |
2021-06-17 |
Wave Life Sciences Ltd. |
Oligonucleotide compositions and methods thereof
|
|
BR102019009665A2
(pt)
*
|
2018-12-21 |
2022-02-08 |
Jacques P. Tremblay |
Modificação da proteína precursora beta amiloide (app) através da edição de base usando o sistema crispr/cas9
|
|
JP2022516515A
(ja)
|
2018-12-31 |
2022-02-28 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
Rna標的化crispr-cas13bを使用するdux4 rna発現停止
|
|
CA3127241A1
(en)
|
2019-01-22 |
2020-07-30 |
Korro Bio, Inc. |
Rna-editing oligonucleotides and uses thereof
|
|
AU2020210900B2
(en)
|
2019-01-22 |
2025-04-24 |
Korro Bio, Inc. |
RNA-editing oligonucleotides and uses thereof
|
|
CN113573717A
(zh)
|
2019-01-22 |
2021-10-29 |
科罗生物公司 |
Rna编辑的寡核苷酸及其用途
|
|
WO2020157014A1
(en)
|
2019-01-28 |
2020-08-06 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for the treatment of leber's congenital amaurosis
|
|
EP3918067A1
(en)
|
2019-01-28 |
2021-12-08 |
ProQR Therapeutics II B.V. |
Rna-editing oligonucleotides for the treatment of usher syndrome
|
|
EP3917497A4
(en)
|
2019-02-01 |
2023-06-07 |
Wave Life Sciences Ltd. |
OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF
|
|
GB201901873D0
(en)
|
2019-02-11 |
2019-04-03 |
Proqr Therapeutics Ii Bv |
Antisense oligonucleotides for nucleic acid editing
|
|
US20220177894A1
(en)
|
2019-04-02 |
2022-06-09 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for immunotherapy
|
|
GB201904709D0
(en)
|
2019-04-03 |
2019-05-15 |
Proqr Therapeutics Ii Bv |
Chemically modified oligonucleotides
|
|
CA3136735A1
(en)
|
2019-04-15 |
2020-10-22 |
Edigene Inc. |
Methods and compositions for editing rnas
|
|
US20220213478A1
(en)
|
2019-04-18 |
2022-07-07 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for the treatment of usher syndrome
|
|
GB201905732D0
(en)
|
2019-04-24 |
2019-06-05 |
Proqr Therapeutics Ii Bv |
RNA editing inhibitors and methods of use
|
|
US20230061732A1
(en)
|
2019-06-05 |
2023-03-02 |
Fukuoka University |
Stable target-editing guide rna having chemically modified nucleic acid introduced thereinto
|
|
WO2020252376A1
(en)
|
2019-06-13 |
2020-12-17 |
Proqr Therapeutics Ii B.V. |
Antisense rna editing oligonucleotides comprising cytidine analogs
|
|
WO2020254249A1
(en)
|
2019-06-21 |
2020-12-24 |
Proqr Therapeutics Ii B.V. |
Delivery of nucleic acids for the treatment of auditory disorders
|
|
AU2020313143B2
(en)
|
2019-07-12 |
2024-04-04 |
Peking University |
Targeted RNA editing by leveraging endogenous adar using engineered RNAs
|
|
CA3143071A1
(en)
|
2019-07-26 |
2021-02-04 |
Proqr Therapeutics Ii B.V. |
Ophthalmic compositions comprising viscosifying polymers and nucleic acids
|
|
CN114174510A
(zh)
|
2019-08-01 |
2022-03-11 |
安斯泰来制药株式会社 |
添加了功能性碱基序列的靶标编辑指导rna
|
|
JP7738323B2
(ja)
|
2019-09-27 |
2025-09-12 |
学校法人福岡大学 |
オリゴヌクレオチド及び標的rnaの部位特異的編集方法
|
|
US11827880B2
(en)
|
2019-12-02 |
2023-11-28 |
Shape Therapeutics Inc. |
Therapeutic editing
|
|
IL293671A
(en)
|
2019-12-09 |
2022-08-01 |
Astellas Pharma Inc |
Antisense guide RNA with an additional functional region for target RNA editing
|
|
US20230039928A1
(en)
|
2019-12-23 |
2023-02-09 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for nucleotide deamination in the treatment of Stargardt disease
|
|
AU2020418026A1
(en)
|
2019-12-30 |
2022-08-18 |
Edigene Therapeutics (Beijing) Inc. |
Method for treating usher syndrome and composition thereof
|
|
AU2020418228A1
(en)
|
2019-12-30 |
2022-08-18 |
Edigene Therapeutics (Beijing) Inc. |
Leaper technology based method for treating MPS IH and composition
|
|
WO2021136520A1
(zh)
|
2019-12-31 |
2021-07-08 |
博雅辑因(北京)生物科技有限公司 |
一种靶向编辑rna的新方法
|
|
WO2021175904A1
(en)
|
2020-03-04 |
2021-09-10 |
Proqr Therapeutics Ii B.V. |
Antisense oligonucleotides for use in the treatment of usher syndrome
|
|
PE20230703A1
(es)
|
2020-04-15 |
2023-04-24 |
Edigene Therapeutics Beijing Inc |
Metodo y farmaco para tratar el sindrome de hurler
|
|
CA3173012A1
(en)
|
2020-04-22 |
2021-10-28 |
Susan BYRNE |
Compositions and methods using snrna components
|
|
EP4158017A1
(en)
|
2020-05-26 |
2023-04-05 |
Shape Therapeutics Inc. |
Engineered circular polynucleotides
|
|
KR102606949B1
(ko)
|
2020-06-26 |
2023-11-29 |
애터미주식회사 |
스마트 칫솔 및 스마트 살균기를 포함하는 구강 관리 시스템
|
|
EP4256050A4
(en)
|
2020-12-01 |
2025-01-22 |
Shape Therapeutics Inc. |
High throughput rna-editing screening methods
|